Quotes About FDA

And so far, their most recent results had been perfect. Their meetings in Germany and Switzerland had gone brilliantly. The testing done in their laboratories there was even more rigorous than what had been done in the States. They were sure now. It was safe. They could move ahead to Phase One Human Trials, as soon as the FDA approved it, which meant giving low doses of the medication to a select number of willing, well-informed subjects, and seeing how they fared.

A lot of great medicines and ancient therapies are blocked by the FDA, so that's why I choose to travel and recognize the value of diverse points of view in medicine.

So far the FDA has only approved them for Hadens. But paraplegics and quadriplegics can benefit from threeps. So can other Americans with mobility issues. So can older Americans whose bodies are failing them in one way or another. The FDA has kept threeps to Haden's victims because jamming a second brain into your head is inherently dangerous, Buchold said. You do it if you have no other choice. But everyone else should still _have_ that choice, Hubbard said.

The food industry, its trade associations, and research foundations, is well financed and highly organized to pressure the FDA.

If you would like food manufacturers to explain more about the chemical ingredients listed on food labels, take up this matter with your congressional representatives. Congress tells the FDA what to do.

In 2012, the U.S. Food and Drug Administration announced newly mandated safety labeling on statin drugs to warn doctors and patients about their potential for brain-related side effects, such as memory loss and confusion.

According to the latest national FDA retail-meat survey, about 90 percent of retail chicken showed evidence of contamination with fecal matter.

In 2012, the U.S. Food and Drug Administration announced newly mandated safety labeling on statin drugs to warn doctors and patients about their potential for brain-related side effects, such as memory loss and confusion. Statin drugs also appeared to increase the risk of developing diabetes.37 In 2013, a study of several thousand breast cancer patients reported that long-term use of statins may as much as double a woman's risk of invasive breast cancer.

If a State has reliable scientific information that demonstrates that a warning is needed for a particular food, then in the interest of public health, it should share that information with the FDA and petition for a new national standard.

Purdue filed papers with the FDA, asking the agency to refuse to accept generic versions of the original formulation of OxyContin—the version the company had been selling all these years—on grounds that it was unsafe. The company said that it was voluntarily withdrawing the original formulation from the market for reasons "of safety.

They "duped the FDA, saying OxyContin lasted twelve hours," Moore said. "They lied about the addictive properties. And they did all this to grow the opioid market, to make it okay to jump in the water. Then some of these other companies, they saw that the water was warm. And they said, 'Okay, we can jump in, too.

So without alerting the FDA, much less asking for permission, Purdue started manufacturing MS Contin at a plant in New Jersey and offered it for sale in October 1984.

As for Curtis Wright, he had been giving some thought, lately, to leaving the federal government. After the approval for OxyContin went through, he resigned from the FDA. Initially, he joined a small pharmaceutical firm in Pennsylvania called Adolor. But he did not stay long. Barely a year later, he moved on, to a new position at Purdue Pharma, in Norwalk, with a first-year compensation package of nearly $400,000.

Barbara Moulton who had spent five years as a drug examiner at the FDA before resigning in protest. The agency had "failed utterly" in its task of policing the way prescription drugs were marketed and sold, she testified. Moulton described an environment at the FDA of unrelenting pressure from the drug companies and a culture in which regulators, rather than regulate the drug companies and their products, showed slavish deference to the private sector.

As I make clear throughout the book, OxyContin was hardly the only opioid to be fraudulently marketed or widely abused, and my choice to focus on Purdue is in no way a suggestion that other pharmaceutical companies do not deserve a great deal of blame for the crisis. The same could be said for the FDA, the doctors who wrote prescriptions, the wholesalers that distributed the opioids, and the pharmacies that filled the prescriptions.

Within the wider context of mainstream medical marijuana and the FDA's designation of MDMA and ketamine as "breakthrough therapies," it was an idea whose time had come.

The FDA constantly approves drugs—not necessarily because they're helpful to the patient but because they bring in money and profits to the huge pharmaceutical industry. True, some of the drugs extend the life of cancer patients—but none of them cure cancer.

the medical system, at least here in the U.S., if something is found that works naturally—something that cannot be patented—it is removed from public view as quickly as possible and discredited as ineffective. At the same time, incredibly dangerous and ineffective synthetic drugs are routinely approved by the FDA and prescribed for the public.